No Data
No Data
Buy Rating Affirmed for Arrowhead Pharmaceuticals Amid Promising Plozasiran Developments
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Truist Secu
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $60
H.C. Wainwright analyst Patrick Trucchio maintains $Arrowhead Pharmaceuticals(ARWR.US)$ with a buy rating, and adjusts the target price from $90 to $60.According to TipRanks data, the analyst has a su
Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Express News | Arrowhead Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $60 From $90
Express News | HC Wainwright & Co. Maintains Buy on Arrowhead Pharma, Lowers Price Target to $60